BioXcel Therapeutics Inc

-0.41 (-3.19%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

BioXcel Therapeutics Inc Stock, NASDAQ:BTAI

555 Long Wharf Drive, 5th floor, New Haven, Connecticut 06511
United States of America
Phone: +1.475.238.6837
Number of Employees: 89


BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on drug development. The firm's two clinical development programs are BXCL501, a sublingual thin film formulation designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and BXCL701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.